Clinical Trial Update: A Study to Evaluate Safety, Tolerability and pK of Semaglutide ER Injectable Suspension in Healthy, Adult Human Subjects [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety, tolerability and pharmacokinetics of Semaglutide ER injectable suspension in healthy adults; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Semaglutide ER Injectable Suspension (semaglutide)

Snippet

Sponsor: Bostal Drug Delivery Co., Ltd | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: NOT_YET_RECRUITING